Associated Papers
Exploring novel MYH7 gene variants using in silico analyses in Korean patients with cardiomyopathy.
Kim OH et al.
Bmc Medical Genomics, 2024
39237976 (PubMed )
Supplement: 12920_2024_2000_MOESM1_ESM.docx
Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies.
Lipov A et al.
Nature Cardiovascular Research, 2023
38666070 (PubMed )
Supplement: 44161_2023_346_MOESM3_ESM.xlsx › S5
Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes.
Ingles J et al.
Circulation. Genomic and Precision Medicine, 2019
30681346 (PubMed )
Supplement: hcg-12-e002460-s002.xlsx › Suppl_Table_8
Cardiomyopathy and Preeclampsia.
Gammill HS et al.
Circulation, 2018
30021846 (PubMed )
Supplement: circ_circulationaha-2017-031527_supp1.pdf
Prevalence and Clinical Implication of Double Mutations in Hypertrophic Cardiomyopathy: Revisiting the Gene-Dose Effect.
Fourey D et al.
Circulation. Cardiovascular Genetics, 2017
A novel mutation of the beta myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy.
Wang J et al.
Clinical Cardiology, 2009
Impact of multiple gene mutations in determining the severity of cardiomyopathy and heart failure.
Tsoutsman T et al.
Clinical and Experimental Pharmacology & Physiology, 2008
MYBPC3 polymorphism is a modifier for expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy.
Wang P et al.
Biochemical and Biophysical Research Communications, 2005
Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland.
Jääskeläinen P et al.
Journal of Molecular Medicine (berlin, Germany), 2002
[Sarcomere gene mutations--a cause of hypertrophic cardiomyopathy].
Kuusisto J et al.
Duodecim; Laaketieteellinen Aikakauskirja, 1999
A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated beta-myosin heavy chain genes.
Jeschke B et al.
Human Genetics, 1998
Select a paper to view details